Table 2.
Growth percentage values of compounds 1-7, 10, and 12 from NCI-60 human tumor cell line screen one-dose assay.
Growth % | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Compound | A549/ATCC | EKVX | HOP-62 | HOP92 | NCI-H226 | NCI-H23 | NCI-H322M | NCI-H460 | NCI-H522 | Average |
1 | 70.78 | 89.40 | 84.22 | 66.99 | 92.61 | 88.32 | 87.60 | 85.07 | 50.99 | 79.55 |
2 | 64.07 | 91.44 | 85.95 | 79.18 | 82.65 | 88.91 | 86.40 | 85.63 | 63.70 | 80.88 |
3 | 62.32 | 82.70 | 67.18 | 67.47 | 81.89 | 77.85 | 84.40 | 75.28 | 56.58 | 72.85 |
4 | 49.31 | 58.07 | 54.76 | 68.41 | 82.03 | 44.04 | 90.05 | 38.24 | 43.40 | 58.70 |
5 | 41.68 | 47.15 | 57.01 | 66.04 | 72.59 | 45.32 | 86.17 | 30.48 | 35.74 | 53.91 |
6 | 38.64 | 37.30 | 55.83 | 59.93 | 69.59 | 30.46 | 76.24 | 24.59 | 33.07 | 47.29 |
7 | 26.68 | 27.92 | 32.56 | n/a | 59.45 | 14.44 | 58.62 | 14.63 | 5.87 | 30.02 |
10 | 18.55 | 13.71 | −4.86 | −23.56 | 39.46 | 5.67 | 34.54 | 11.00 | −72.29 | 2.47 |
12 | −74.19 | −62.61 | −58.01 | −68.19 | −42.06 | −80.31 | −18.39 | −69.88 | −74.23 | −60.87 |